Lupin Gets USFDA Approval for Generic Hypertension Drug

Share:    

Jan 14, 2024 16:14

Lupin receives USFDA approval to market generic hypertension drug Propranolol Hydrochloride extended-release capsules in the US, a generic version of ANI Pharmaceuticals' Inderal LA.
Lupin Gets USFDA Approval for Generic Hypertension Drug
New Delhi, Jan 14 (PTI) Drug maker Lupin on Sunday said it has received approval from the US health regulator to market a generic hypertension drug in America.

The company has received approval from the US Food and Drug Administration (USFDA) for Propranolol Hydrochloride extended-release capsules in multiple strengths, Lupin Ltd said in a regulatory filing.

The company's product is the generic version of ANI Pharmaceuticals' Inderal LA extended-release capsules, it added.


The product will be manufactured at the company's Pithampur-based manufacturing plant, the drug firm stated.

Propranolol Hydrochloride extended-release capsules USP are indicated in the management of hypertension.

They may be used alone or in combination with other antihypertensive agents, particularly a thiazide diuretic.

As per IQVIA MAT November 2023 data, Propranolol Hydrochloride extended-release capsules had estimated annual sales of USD 71 million in the US.
Share:    

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

See More >

Moneywiz Live!

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback